The effect of clarithromycin on inflammatory markers in chronic obstructive pulmonary disease: Preliminary data


BAŞYİĞİT İ. , YILDIZ F. F. , ÖZKARA S. , YILDIRIM E., BOYACI H. , ILGAZLI A. H.

ANNALS OF PHARMACOTHERAPY, vol.38, no.9, pp.1400-1405, 2004 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 38 Issue: 9
  • Publication Date: 2004
  • Doi Number: 10.1345/aph.1d634
  • Title of Journal : ANNALS OF PHARMACOTHERAPY
  • Page Numbers: pp.1400-1405

Abstract

BACKGROUND: Clarithromycin is an antimicrobial agent that can be used for treatment of chronic obstructive pulmonary disease (COPD) exacerbations with bronchodilator therapy. However, it has also been shown that clarithromycin has antiinflammatory effects by the inhibition of cytokine production.